Alvotech (BX:ALVOUSD) Financings
Financings
| Raise | Date | In US dollars |
|---|---|---|
| Public offering of ordinary shares Closed: US$98M raised · US$3.75 a share · BofA Securities +2 Dealers: BofA Securities (co-lead), Jefferies (co-lead), Evercore ISI (co-lead) Use of proceeds: Continued development of biosimilar assets, working capital and general corporate purposes | Jun 18, 2026 | |
| Private placement of ordinary shares Announced: about US$67M · US$3.75 a share Use of proceeds: Continued development of biosimilar assets, working capital and general corporate purposes | Jun 18, 2026 | |
| Senior unsecured convertible bonds due 2030 Made bigger: US$108M · DNB Carnegie Dealers: DNB Carnegie (lead) Use of proceeds: Continued investment in the R&D pipeline, scaling up production and global product launches. | Dec 17, 2025 | |
| Private placement of sDRs and ordinary shares Closed: DNB Carnegie Investment Bank AB (publ) +3 Dealers: DNB Carnegie Investment Bank AB (publ) (co-lead), Citigroup Global Markets Limited (co-lead), Skandinaviska Enskilda Banken AB (publ) (co-lead), ACRO Securities HF (co-lead) Use of proceeds: Accelerate R&D activities, especially in Sweden after the Xbrane R&D acquisition, expand pipeline, and general corporate purposes | Jun 11, 2025 | |
| Public offering of swedish Depository Receipts (SDRs) Update: about SEK 39M · SEK 87.51 a receipt · DNB Markets, a part of DNB Bank ASA, Sweden Branch +2 Dealers: DNB Markets, a part of DNB Bank ASA, Sweden Branch, Carnegie Investment Bank, DNB Carnegie Investment Bank AB (publ) | May 19, 2025 | US$3.99M |